Evidence map›Paper›PMID 39255326›Full record

ArticlePLoS computational biology2024

Construct prognostic models of multiple myeloma with pathway information incorporated.

Shuo Wang, ShanJin Wang, Wei Pan, YuYang Yi, Junyan Lu

Abstract read
In one paragraph

Article in PLoS computational biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shuo WangDepartment of Spinal Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
ShanJin WangDepartment of Spinal Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Wei PanDepartment of Spinal Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
YuYang YiDepartment of Spinal Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Junyan LuInstitute of Computation Biomedicine and Center for Infectiology, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.ORCID 0000-0002-9211-0746

Funding

German Federal Ministry of Education and Research 161L0213Key Projects of Natural Science Foundation of Jiangxi Province 20212ACB206032Leader Training Plan of Pudong New Area Health Commission PWRD2020-11Training Program for Academic and Technical Leaders of Major Disciplines in Jiangxi Province-Leading Talents Project 20213BCJ22011
6 · The paper itself

Abstract

Multiple myeloma (MM) is a hematological disease exhibiting aberrant clonal expansion of cancerous plasma cells in the bone marrow. The effects of treatments for MM vary between patients, highlighting the importance of developing prognostic models for informed therapeutic decision-making. Most previous models were constructed at the gene level, ignoring the fact that the dysfunction of the pathway is closely associated with disease development and progression. The present study considered two strategies that construct predictive models by taking pathway information into consideration: pathway score method and group lasso using pathway information. The former simply converted gene expression to sample-wise pathway scores for model fitting. We considered three methods for pathway score calculation (ssGSEA, GSVA, and z-scores) and 14 data sources providing pathway information. We implemented these methods in microarray data for MM (GSE136324) and obtained a candidate model with the best prediction performance in interval validation. The candidate model is further compared with the gene-based model and previously published models in two external data. We also investigated the effects of missing values on prediction. The results showed that group lasso incorporating Vax pathway information (Vax(grp)) was more competitive in prediction than the gene model in both internal and external validation. Immune information, including VAX pathways, seemed to be more predictive for MM. Vax(grp) also outperformed the previously published models. Moreover, the new model was more resistant to missing values, and the presence of missing values (<5%) would not evidently deteriorate its prediction accuracy using our missing data imputation method. In a nutshell, pathway-based models (using group lasso) were competitive alternatives to gene-based models for MM. These models were documented in an R package (https://github.com/ShuoStat/MMMs), where a missing data imputation method was also integrated to facilitate future validation.

Indexed as

Computational BiologyMultiple MyelomaDatabases, GeneticGene Expression ProfilingGene Expression Regulation, NeoplasticHumansModels, BiologicalPrognosisSignal Transduction

Identifiers

PMID39255326
PMCPMC11414978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.